Analytical testing, QC

UK-based CRO Cresset and Elixir aim to brew new drug discovery platform

18-Oct-2018 By Maggie Lynch

The CRO and software provider for small molecule discovery, Cresset, is collaborating with Elixir to create a new platform for efficient drug discovery.

Collaboration accelerates patient enrollment in genetic Parkinson’s study

10-Oct-2018 By Maggie Lynch

Centogene and Denali entered a strategic collaboration to identify and recruit patients with a gene mutation to be enrolled in a Parkinson’s disease study.

People on the Move: Outsourcing-Pharma roundup September '18

05-Oct-2018 By Melissa Fassbender

Metrion has bolstered its drug discovery leadership team, CluePoints has upped its RBM services, and Concept Life Sciences has added to its analytical services division, among other moves this month in the outsourced pharmaceutical services industry.

Altasciences aims to create a new outsourcing paradigm, not to be the biggest: CEO

02-Oct-2018 By Melissa Fassbender

Altasciences’ acquisition of a preclinical testing business marks the “next major milestone” in the CRO’s goal to provide an integrated offering from lead candidate selection to proof of concept.

CDMO PharmaBlock purchases Chinese facility to meet increasing demand

02-Oct-2018 By Melissa Fassbender

The China-headquartered CDMO PharmaBlock has purchased a GMP compliant manufacturing facility and is investing in new technology and capacity to support clients long term, says chairman.

GA-based CDMO picked up by private equity

01-Oct-2018 By Melissa Fassbender

The middle-market private equity firm Nautic Partners has acquired Mikart, an Atlanta, GA-headquartered contract development and manufacturing organization (CDMO).

Brammer Bio advancing 3 year, $200m program: 700 employees expected by mid-2019

27-Sep-2018 By Melissa Fassbender

Brammer Bio’s three-year, $200m investment program is set to establish more than 30 suites for both clinical and commercial viral vector supply.

OTC test lab or microbrewery? US FDA warns lab for mixing beer tech with media

24-Sep-2018 By Flora Southey

The US FDA has issued a warning letter to contract testing laboratory Pharmaceutical Laboratories and Consultants, Inc., after a microbrewery was found to be operating in shared space.

Sekisui XenoTech expands test systems with rodent, monkey hepatocytes

13-Sep-2018 By Melissa Fassbender

Sekisui XenoTech is expanding its catalog of CryostaX in vitro drug discovery and preclinical drug development test systems.

BioIVT: New research sheds light on the mechanisms underlying C-DILI assay

12-Sep-2018 By Melissa Fassbender

BioIVT’s research on the mechanisms underlying the C-DILI assay introduces “a new paradigm,” which suggests BSEP inhibition alone will not lead to bile acid-induced liver injury, says study director.

Recruitment remedy? Antidote teams with direct-to-patient lab to screen clinical trial participants

10-Sep-2018 By Melissa Fassbender

The digital health company Antidote Technologies is partnering with PWNHealth, a virtual care company that provides direct-to-patient (DTP) lab services.

People on the Move: Outsourcing-Pharma roundup August '18

07-Sep-2018 By Melissa Fassbender

This month marked the effective start date for Parexel's new executive VP and CFO Greg Rush, who joins August's People on the Move with several other c-suite hires, including a new CEO at Citoxlab and COO at ProSciento.

Merck taps Italian CRO IRBM for peptide drug development

06-Sep-2018 By Melissa Fassbender

IRBM and Merck have signed a new agreement in the peptide therapeutics area through which the Italian CRO will identify potential peptide leads for a specific Merck target.

AMRI, Metrion Biosciences team up to provide ion channel drug discovery services

06-Sep-2018 By Melissa Fassbender

The outsourced service providers have signed a new collaboration agreement to provide global pharmaceutical and biotechnology clients access to electrophysiology and ion channel screening.

SGS adds PBMC analysis for early phase clinical trials to lineup at CPU

05-Sep-2018 By Melissa Fassbender

The contract services provider is now collecting and using peripheral blood mononuclear cells (PBMCs) for early phase clinical trials at its Antwerp, Belgium-based Clinical Pharmacology Unit (CPU).

SGS opening new biopharma testing lab in Geneva

28-Aug-2018 By Melissa Fassbender

The analytical and bioanalytical contract solutions provider SGS is expanding its biopharmaceutical testing capabilities in Geneva, Switzerland.

Charles River eyes global M&A opportunities, expects to double size in 5 years

16-Aug-2018 By Melissa Fassbender

Fueled by increasing investments from biotech, Charles River expects to double the size of its business over the next five years – organically and through M&A – to become a ‘more responsive partner,’ says CEO.

UK reaffirms commitment to ‘a competitive service for clinical trial assessment’ post Brexit

15-Aug-2018 By Melissa Fassbender

In an update on the implementation of the new Clinical Trials Regulation, the MHRA expresses increased confidence that the UK will exit the EU with a deal – and reaffirms its commitment to align with parts of the legislation “within the UK’s control.”

Medpace surprises with Q2 2018 revenue growth: ‘Things have been running very smoothly’

09-Aug-2018 By Melissa Fassbender

Revenue growth has taken off, driven by steady start-up on several programs, as the CRO remains focused on its core market of small and midsized biopharma – which makes up the majority of its revenue.

State of the Industry: What readers have to say

08-Aug-2018 By Melissa Fassbender

Outsourcing-Pharma recently conducted a second ‘state of the industry’ survey to gauge views about the current state of the global pharmaceutical outsourcing market and the evolving relationships of those involved.

LabCorp continues to invest in ‘the CRO of the future’

07-Aug-2018 By Melissa Fassbender

LabCorp signed several partnership deals in the second quarter of 2018 as the company aims to enhance the drug development process and continues to invest in its CRO business.

Big data, AI tech at the center of ALS Association partnership with GNS

02-Aug-2018 By Maggie Lynch

GNS Healthcare will use its machine learning platform to create an ALS disease model to further research and understanding of the disease.

Concept registers across the pond to offer pharma testing for US market

19-Jul-2018 By Flora Southey

UK-headquartered Concept Life Sciences says completing FDA registration means it can test raw pharmaceutical materials and finished products for the US market.

DIA 2018

The nexus of innovation, policy improvements changing at never-before-seen pace: DIA

10-Jul-2018 By Melissa Fassbender

Cross-industry discussion is expanding from early discovery to post-licensing challenges – as the nexus of innovation and policy improvements is rapidly changing, says DIA executive.

BioIVT 'better positioned' to support ADME-Tox clients with Optivia purchase

09-Jul-2018 By Melissa Fassbender

BioIVT adds transporter assay products and services to its ADME-Toxicology portfolio with the acquisition of Optivia Biotechnology – a deal which aligns with the company’s efforts to support drug safety and efficacy, says VP.

Catalent eyes early-phase work with $133m Juniper acquisition

03-Jul-2018 By Melissa Fassbender

Catalent is set to acquire Juniper Pharmaceuticals in a $133m deal, which will provide the CDMO with a new European hub and the ability to win a larger share of early-phase development programs says exec.

Novacap acquires PCI Synthesis to expand offering in the US

20-Jun-2018 By Melissa Fassbender

France-based Novacap is set to acquire PCI Synthesis – a CDMO located near Boston’s biotech hub – to expand its pharmaceutical offerings in the US.

Life science advances and gender equity on the program for DIA 2018

19-Jun-2018 By Melissa Fassbender

This year’s DIA Global Annual Meeting will focus on the latest global trends and showcase the "diverse group of key individuals driving the life science ecosystem forward," says DIA Americas managing director.

Evotec takes on Sanofi’s infectious disease unit as it aims to develop new anti-infectives

18-Jun-2018 By Melissa Fassbender

Evotec is integrating Sanofi’s infectious disease unit into its organization and will collaborate to launch new "open innovation" initiatives aimed at accelerating infectious disease research.

Cambrex expands in Italy and Sweden: New hires, labs to be ready in 2019

13-Jun-2018 By Melissa Fassbender

Cambrex’s news that it will be constructing a research and development laboratory at its Italy-based site follows on the heels of its recently announced plans to begin a $5m expansion in Sweden.

Wasdell invests £500k in new UK-based lab, offerings to be replicated in Ireland

11-Jun-2018 By Melissa Fassbender

Wasdell Group is investing £500k ($669k) in a new laboratory as the first phase of an expansion strategy, which includes a similar investment in Ireland "to cater for all situations after Brexit," says managing director.

State of the Industry

State of the Industry: Taking the pulse of the contract services market

11-Jun-2018 By Melissa Fassbender

Following on from the success of last year's survey, Outsourcing-Pharma is running another 'state of the industry' survey to gauge views about the current state of the pharmaceutical contract services industry.

Smallpox treatment nears FDA approval after years of development, collaboration

11-Jun-2018 By Melissa Fassbender

SIGA is slated to receive FDA approval for the world’s first antiviral drug to treat smallpox – a milestone not reached in isolation, but in collaboration with several CROs, government agencies, and others.

Preclinical CRO Admescope acquires MetaSafe to up drug metabolism services

07-Jun-2018 By Melissa Fassbender

The preclinical contract research organization (CRO) Admescope has acquired MetaSafe in a deal which will bolster its drug metabolism services for clinical phase projects.

PPD: Meeting biopharma demand is a ‘substantial undertaking’ for CRO industry

07-Jun-2018 By Melissa Fassbender

PPD Laboratories SVP says its been a substantial undertaking – for every company in the CRO industry – to meet the demand for biopharmaceuticals as the industry's pipeline continues to expand.

BIO 2018

Outsourcing-Pharma

Resources